These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 17953654

  • 1. Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease.
    Pandey M, Varghese M, Sindhu KM, Sreetama S, Navneet AK, Mohanakumar KP, Usha R.
    J Neurochem; 2008 Jan; 104(2):420-34. PubMed ID: 17953654
    [Abstract] [Full Text] [Related]

  • 2. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide.
    Kumar P, Kumar A.
    Behav Brain Res; 2010 Jan 05; 206(1):38-46. PubMed ID: 19716383
    [Abstract] [Full Text] [Related]

  • 3. Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats.
    Pandey M, Borah A, Varghese M, Barman PK, Mohanakumar KP, Usha R.
    Neurochem Int; 2009 Nov 05; 55(6):431-7. PubMed ID: 19410615
    [Abstract] [Full Text] [Related]

  • 4. Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
    Dhir A, Akula KK, Kulkarni SK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):835-43. PubMed ID: 18234412
    [Abstract] [Full Text] [Related]

  • 5. Protective effects of ginseng saponins on 3-nitropropionic acid-induced striatal degeneration in rats.
    Kim JH, Kim S, Yoon IS, Lee JH, Jang BJ, Jeong SM, Lee JH, Lee BH, Han JS, Oh S, Kim HC, Park TK, Rhim H, Nah SY.
    Neuropharmacology; 2005 Apr 01; 48(5):743-56. PubMed ID: 15814108
    [Abstract] [Full Text] [Related]

  • 6. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
    Kumar P, Kumar A.
    Eur J Pharmacol; 2009 Aug 01; 615(1-3):91-101. PubMed ID: 19445928
    [Abstract] [Full Text] [Related]

  • 7. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats.
    Tariq M, Khan HA, Elfaki I, Al Deeb S, Al Moutaery K.
    Brain Res Bull; 2005 Sep 30; 67(1-2):161-8. PubMed ID: 16140176
    [Abstract] [Full Text] [Related]

  • 8. Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype.
    Tadros MG, Khalifa AE, Abdel-Naim AB, Arafa HM.
    Pharmacol Biochem Behav; 2005 Nov 30; 82(3):574-82. PubMed ID: 16337998
    [Abstract] [Full Text] [Related]

  • 9. Discriminative behavioral assessment unveils remarkable reactive astrocytosis and early molecular correlates in basal ganglia of 3-nitropropionic acid subchronic treated rats.
    Cirillo G, Maggio N, Bianco MR, Vollono C, Sellitti S, Papa M.
    Neurochem Int; 2010 Jan 30; 56(1):152-60. PubMed ID: 19799953
    [Abstract] [Full Text] [Related]

  • 10. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
    Lastres-Becker I, Hansen HH, Berrendero F, De Miguel R, Pérez-Rosado A, Manzanares J, Ramos JA, Fernández-Ruiz J.
    Synapse; 2002 Apr 30; 44(1):23-35. PubMed ID: 11842443
    [Abstract] [Full Text] [Related]

  • 11. 3-nitropropionic acid-induced mitochondrial permeability transition: comparative study of mitochondria from different tissues and brain regions.
    Mirandola SR, Melo DR, Saito A, Castilho RF.
    J Neurosci Res; 2010 Feb 15; 88(3):630-9. PubMed ID: 19795369
    [Abstract] [Full Text] [Related]

  • 12. Metabolic profiling of 3-nitropropionic acid early-stage Huntington's disease rat model using gas chromatography time-of-flight mass spectrometry.
    Chang KL, New LS, Mal M, Goh CW, Aw CC, Browne ER, Chan EC.
    J Proteome Res; 2011 Apr 01; 10(4):2079-87. PubMed ID: 21355552
    [Abstract] [Full Text] [Related]

  • 13. N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington's disease.
    Sandhir R, Sood A, Mehrotra A, Kamboj SS.
    Neurodegener Dis; 2012 Apr 01; 9(3):145-57. PubMed ID: 22327485
    [Abstract] [Full Text] [Related]

  • 14. Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity.
    Ahuja M, Bishnoi M, Chopra K.
    Toxicology; 2008 Feb 28; 244(2-3):111-22. PubMed ID: 18164115
    [Abstract] [Full Text] [Related]

  • 15. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).
    Pérez-De La Cruz V, González-Cortés C, Galván-Arzate S, Medina-Campos ON, Pérez-Severiano F, Ali SF, Pedraza-Chaverrí J, Santamaría A.
    Neuroscience; 2005 Feb 28; 135(2):463-74. PubMed ID: 16111817
    [Abstract] [Full Text] [Related]

  • 16. Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease.
    Lee ST, Park JE, Kim DH, Kim S, Im WS, Kang L, Jung SH, Kim MW, Chu K, Kim M.
    Brain Res; 2008 Feb 15; 1194():130-7. PubMed ID: 18166168
    [Abstract] [Full Text] [Related]

  • 17. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease.
    Keene CD, Rodrigues CM, Eich T, Linehan-Stieers C, Abt A, Kren BT, Steer CJ, Low WC.
    Exp Neurol; 2001 Oct 15; 171(2):351-60. PubMed ID: 11573988
    [Abstract] [Full Text] [Related]

  • 18. Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration.
    Hariharan A, Shetty S, Shirole T, Jagtap AG.
    Neurotoxicology; 2014 Dec 15; 45():139-48. PubMed ID: 25445565
    [Abstract] [Full Text] [Related]

  • 19. In vivo dopamine release and uptake impairments in rats treated with 3-nitropropionic acid.
    Kraft JC, Osterhaus GL, Ortiz AN, Garris PA, Johnson MA.
    Neuroscience; 2009 Jul 07; 161(3):940-9. PubMed ID: 19362126
    [Abstract] [Full Text] [Related]

  • 20. Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production.
    Villarán RF, Tomás-Camardiel M, de Pablos RM, Santiago M, Herrera AJ, Navarro A, Machado A, Cano J.
    Neurotoxicology; 2008 Mar 07; 29(2):244-58. PubMed ID: 18093658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.